Analysts came away from a meeting with Viking’s management with an update on the program that included their thinking on how they would scale up ... while the SPDR S&P Biotech ETF has gained ...

The situation highlights “the difficulty a competitor would have coming into the market with a biosimilar,” says senior biotech analyst ... FDA's approval for scale-up projects.

“When scaling up a process based on adherent cells, a biopharmaceutical manufacturer has two options. Either stay in 2D, resulting in the use of heavy and difficult-to-handle multi-tray stacks with a ...

"We’re excited to partner with PharmNXT Biotech to introduce our products ... greater volumetric productivity from the bench through scale-up manufacturing. With this approach, the system ...